- Welcome Physicians
- About RADIESSE Dermal Filler
- Uses & Limitations
- Clinical Education
- Clinical Studies
- Marketing Support
- Patient Access Program
- Insurance Reimbursement
To view more before and after cases, click here.
Radiesse® Dermal Filler - Welcome Physicians
Thank you for your interest in Radiesse® dermal filler, the FDA-approved filler that is aiming to become the new standard for the correction of Facial Lipoatrophy in people with HIV. RADIESSE dermal filler also has received FDA – approval for the correction of moderate to severe facial wrinkles and folds, including nasolabial folds, and has long been used to treat vocal fold paresis and paralysis, and oral-maxillofacial defects, and has been used as a radiographic tissue marker. Clinical studies have shown Radiesse to be safe, provide both immediate and long-lasting correction, with outstanding patient satisfaction results.
Only RADIESSE dermal filler contains advanced, smooth calcium hydroxylapatite (CaHA) microspheres that provide both immediate and long-lasting results. The microspheres are suspended in a water-based gel. Once injected, RADIESSE filler stimulates the body to produce new collagen. In addition to great long-lasting clinical results, RADIESSE treatment is also a convenient procedure for physicians to deliver as it does not require reconstitution. The results are immediate and long-lasting enabling you to give your patients great value that helps build long-term patient relationships.
This section of the Website is your resource for in-depth information about RADIESSE dermal filler. You can learn more about our clinical education, training, practice development, and RADIESSE Patient Access Program.